학술논문

Stroke in HIV
Document Type
article
Source
Canadian Journal of Cardiology. 35(3)
Subject
Medical Microbiology
Biomedical and Clinical Sciences
Aging
Brain Disorders
Infectious Diseases
Prevention
HIV/AIDS
Stroke
Neurosciences
Clinical Research
2.4 Surveillance and distribution
Aetiology
Infection
Good Health and Well Being
HIV Infections
Humans
Prevalence
Risk Factors
Risk Reduction Behavior
Secondary Prevention
Cardiorespiratory Medicine and Haematology
Cardiovascular System & Hematology
Cardiovascular medicine and haematology
Language
Abstract
Stroke is a heterogeneous disease in persons living with human immunodeficiency virus (HIV). HIV is thought to increase the risk of stroke through both HIV-related and traditional stroke risk factors, which vary with respect to the patient's age and clinical characteristics. Numerous studies show that detectable viremia and immunosuppression increase the risk of stroke across all ages, whereas traditional risk factors are more common in the aging population with HIV. As persons living with HIV age and acquire traditional stroke risk factors, the prevalence of stroke will likely continue to increase. Large- and small-vessel disease are the most common causes of stroke, although it is important to evaluate for infectious etiology as well. Research regarding the management of stroke in patients with HIV is scant, and recommendations often parallel those for the general population. Treatment of HIV and effective reduction of traditional stroke risk factors is important to reduce the risk of stroke in persons living with HIV. Future research will help elucidate the pathophysiology of HIV and stroke risk, investigate sex differences in stroke risk, and evaluate the safety and benefits of standard stroke preventative measures and HIV-specific interventions in this population.